MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
DexCom EV/EBITDA Ratio 2011-2026 | DXCM
Annual EV/EBITDA Ratio DexCom
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 39.5 | 98.4 | 117 | -79.8 | -190 | -132 | -121 | -338 | -126 | -21 | -17.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 117 | -338 | -70 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
-43.6 | - | - | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 29.8 | -3.87 % | $ 321 M |  China |
 |
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
3.62 | - | - | $ 79.8 M | USA |
 |
BioNano Genomics
BNGO
|
-7.71 | $ 1.13 | -3.54 % | $ 1.44 M | USA |
 |
Castle Biosciences
CSTL
|
-21.2 | - | - | $ 914 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
20.1 | $ 219.93 | 0.09 % | $ 161 B | USA |
 |
Celcuity
CELC
|
-2.38 | $ 104.25 | 0.08 % | $ 4.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 209.75 | 2.09 % | $ 23.3 B | USA |
 |
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | USA |
 |
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-100 | $ 19.51 | -5.18 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
-1.05 | $ 11.07 | 1.37 % | $ 314 M | Israel |
 |
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.42 | - | $ 19.2 B | USA |
 |
Interpace Biosciences
IDXG
|
-6.02 | $ 1.82 | - | $ 7.98 M | USA |
 |
Lantheus Holdings
LNTH
|
-187 | $ 67.04 | - | $ 4.64 B | USA |
 |
Fulgent Genetics
FLGT
|
2.58 | $ 23.02 | - | $ 696 M | USA |
 |
Mettler-Toledo International
MTD
|
827 | - | -0.62 % | $ 28.7 B |  Schweiz |
 |
Guardant Health
GH
|
-28.8 | $ 106.6 | 1.65 % | $ 13.1 B | USA |
 |
NeoGenomics
NEO
|
-33.5 | $ 11.47 | - | $ 1.45 B | USA |
 |
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B |  Niderland |
 |
Natera
NTRA
|
-19.5 | - | -0.5 % | $ 20.7 B | USA |
 |
OPKO Health
OPK
|
25.9 | $ 1.25 | 2.05 % | $ 868 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
22 | - | -9.16 % | $ 8.49 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
55.6 | $ 32.03 | -2.72 % | $ 20 B | Niderland |
 |
IDEXX Laboratories
IDXX
|
45.3 | - | - | $ 53.5 B | USA |
 |
Illumina
ILMN
|
70.5 | $ 117.01 | -1.95 % | $ 18.6 B | USA |
 |
IQVIA Holdings
IQV
|
24.1 | $ 176.27 | - | $ 32 B | USA |
|
Biodesix
BDSX
|
-4.25 | - | - | $ 1.33 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 289.4 | 1.75 % | $ 24.3 B | USA |
 |
ENDRA Life Sciences
NDRA
|
0.831 | $ 3.56 | -4.56 % | $ 1.91 M | USA |
 |
ICON Public Limited Company
ICLR
|
38 | - | - | $ 11 B |  Irlanda |
 |
Quidel Corporation
QDEL
|
9.16 | - | -3.13 % | $ 1.19 B | USA |
 |
Biomerica
BMRA
|
-6.24 | $ 2.23 | - | $ 5.12 M | USA |
 |
Bioventus
BVS
|
26.4 | $ 8.04 | - | $ 504 M | USA |